A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

July 31, 2031

Conditions
Urea Cycle Disorders
Interventions
DRUG

Glycerol phenylbutyrate Oral Liquid

"Administration and dosage: The recommended total daily dose of glycerol phenylbutyrate is calculated based on the patient's body surface area, ranging from 4.5 mL/m2/d to 11.2 mL/m2/d:~1. Recommended initial dose in phenylbutyrate-naïve patients~ * Patients with body surface area (BSA) \< 1.3 m2: 8.5 mL/m2/day~ * Patients with body surface area (BSA) ≥ 1.3 m2: 7 mL/m2/day~2. Initial dose for patients switching from sodium phenylbutyrate to glycerol phenylbutyrate: Total daily dose of glycerol phenylbutyrate (ml) = total daily dose of sodium phenylbutyrate granules (g) ×0.81 Medication Schedule: The daily total dose should be divided into equal amounts and administered with each meal or feeding (such as three to six times daily)."

Trial Locations (4)

100034

NOT_YET_RECRUITING

Peking University First Hospital, Beijing

200092

NOT_YET_RECRUITING

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

430030

RECRUITING

Tongji Hosipital, Wuhan

510000

NOT_YET_RECRUITING

Guangzhou Women and Children's Medical Center, Guangzhou

All Listed Sponsors
lead

Tongji Hospital

OTHER

NCT06904027 - A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders | Biotech Hunter | Biotech Hunter